Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -64.13-23.46-24.787.6324.25

What is the latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS is -64.13 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-64.13
Mar2025-23.46
Mar2024-24.78
Mar20237.63
Mar202224.25

How is Core EBITDA Growth of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 -64.13
Negative
Mar2025 -23.46
Negative
Mar2024 -24.78
Negative
Mar2023 7.63
-68.54
Mar2022 24.25 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹120.1 Cr -1.9% -5.6% -49.5% Stock Analytics
ADANI ENTERPRISES ₹359,549.0 Cr -1.4% -9.2% 9.7% Stock Analytics
ADITYA INFOTECH ₹49,162.4 Cr -8.2% 18.8% 197.8% Stock Analytics
AEGIS LOGISTICS ₹46,749.7 Cr -4.3% -1.5% 68.6% Stock Analytics
PREMIER ENERGIES ₹40,821.6 Cr -0.1% 1.8% -12.5% Stock Analytics
REDINGTON ₹29,003.8 Cr -5.4% -7.3% 37.5% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-1.9%

-5.6%

-49.5%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses